Tapentadol Market

Tapentadol is an analgesic with a dual mode of action as a norepinephrine reuptake inhibitor and an agonist of the mu-opioid receptor. Its analgesic properties come into effect within few minutes of oral administration.
Tapentadol Market contains market size and forecasts of Tapentadol in global, including the following market information:

• Global Tapentadol Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Tapentadol Market Sales, 2017-2022, 2023-2028, (K Pcs)
• Global top five Tapentadol companies in 2021 (%)

The global Tapentadol market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
100 mg Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tapentadol include Johnson & Johnson Pharmaceutical Research & Development, IPCA Laboratories, Lupin Laboratories, Ranbaxy Laboratories, Aristo Pharmaceuticals, Cadila Pharmaceuticals and Tirupati Medicare, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tapentadol manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tapentadol Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tapentadol Market Segment Percentages, by Type, 2021 (%)

• 100 mg Tablets
• 75 mg Tablets
• 50 mg Tablets

Global Tapentadol Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tapentadol Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Pharmacy
• Other

Global Tapentadol Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tapentadol Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Tapentadol revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Tapentadol revenues share in global market, 2021 (%)
• Key companies Tapentadol sales in global market, 2017-2022 (Estimated), (K Pcs)
• Key companies Tapentadol sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Johnson & Johnson Pharmaceutical Research & Development
• IPCA Laboratories
• Lupin Laboratories
• Ranbaxy Laboratories
• Aristo Pharmaceuticals
• Cadila Pharmaceuticals
• Tirupati Medicare

To know more about market statistics, Download a FREE Sample copy